![](https://investorshub.advfn.com/uicon/315468.png?cb=1473363790)
Friday, July 27, 2018 10:44:44 AM
From the Balance sheet etc the OWCP valuation would be a trips stock.
There isn't any assets - there isn't any revenue - there isn't any IP (patents) - there isn't any proof that OWCP has completed any research or clinical trials - since 2014 OWCP hasn't published any research or clinical data. Then there is the missing efficacy report.
OWCP promises a great deal. But never delivers anything.
There isn't any real valuation that would put the price at 0.50 - complete nonsense.
IG
Hi, How Are You
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM